题名 | Dexmedetomidine Promotes Angiogenesis and Vasculogenic Mimicry in Human Hepatocellular Carcinoma through alpha 2-AR/HIF-1 alpha/VEGFA Pathway* |
作者 | |
发表日期 | 2022-10 |
发表期刊 | BIOMEDICAL AND ENVIRONMENTAL SCIENCES 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | Hepatocellular carcinoma Dexmedetomidine Yohimbine ?2-adrenergic receptor HIF-1a VEGFA Vascular mimicry Angiogenesis |
其他关键词 | HIF-1-ALPHA ; HYPOXIA |
摘要 | Objective Dexmedetomidine (DEX), the most specific alpha 2-adrenergic receptor agonist widely used for its sedative and analgesic properties, has been reported to upregulate HIF-1 alpha expression to protect hypoxic and ischemic tissues. However, it is largely unclear whether DEX can also upregulate Hypoxia-inducible factor-1 alpha (HIF-1 alpha) expression and its downstream vascular endothelial growth factor-A (VEGFA) in cancer tissues with oxygen-deficient tumor microenvironment. Methods We used SMMC-7721 cells, MHCC97-H cells, and a mouse model of orthotopic hepatic carcinoma to explore the effect of DEX on angiogenesis and vasculogenic mimicry (VM) and its mechanism. Under normoxic (20% O2) and hypoxic (1% O2) conditions, DEX was used to intervene cells, and yohimbine was used to rescue them. Results The results showed that DEX promoted angiogenesis and VM in human liver cancer cells within a certain dose range, and the addition of yohimbine inhibited this effect. DEX could activate HIF-1 alpha/VEGFA pathway, which was further verified by silencing HIF-1 alpha. Consistently, in vivo results also showed that DEX can up-regulate HIF-1 alpha/VEGFA expression, and enhance the number of VM channels and microvessel density (MVD). Conclusion We believe that HIF-1 alpha/VEGFA might be an important signaling pathway by which DEX promotes angiogenesis and VM formation in human hepatocellular carcinoma, whereas alpha 2-adrenergic receptor mediation might be the critical mechanisms. |
资助项目 | Natural Science Foundation of Zhejiang Province; Science and Technology Research Program of Jinhua City; [LY19H160002]; [2018-3-001b]; [2017-3-020] |
出版者 | CHINESE CENTER DISEASE CONTROL & PREVENTION |
出版地 | BEIJING |
ISSN | 0895-3988 |
EISSN | 2214-0190 |
卷号 | 35期号:10页码:931-942 |
DOI | 10.3967/bes2022.120 |
页数 | 12 |
WOS类目 | Environmental Sciences ; Public, Environmental & Occupational Health |
WOS研究方向 | Environmental Sciences & Ecology ; Public, Environmental & Occupational Health |
WOS记录号 | WOS:000891773100007 |
收录类别 | SCIE ; SCOPUS ; PUBMED |
URL | 查看原文 |
PubMed ID | 3644327 |
SCOPUSEID | 2-s2.0-85142828630 |
通讯作者地址 | [LI, Tian Zuo]Department of Anesthesiology,Beijing Shijitan Hospital,Capital Medical University,Beijing,100038,China ; [MIAO, Hui Hui]Department of Anesthesiology,Beijing Shijitan Hospital,Capital Medical University,Beijing,100038,China |
Scopus学科分类 | Public Health, Environmental and Occupational Health;Health, Toxicology and Mutagenesis |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/172136 |
专题 | 附属第一医院_麻醉科 温州医科大学 |
通讯作者 | MIAO, Hui Hui; LI, Tian Zuo |
作者单位 | 1.Department of Anesthesiology,Beijing Shijitan Hospital,Capital Medical University,Beijing,100038,China; 2.Department of Anesthesiology,The Affiliated Jinhua Hospital of Wenzhou Medical University,Zhejiang,Jinhua,321000,China; 3.IVF centre,The Affiliated Jinhua Hospital of Wenzhou Medical University,Zhejiang,Jinhua,321000,China |
第一作者单位 | 附属第一医院_麻醉科 |
推荐引用方式 GB/T 7714 | FANG, Tao,LIN, Li,YE, Zhi Jian,et al. Dexmedetomidine Promotes Angiogenesis and Vasculogenic Mimicry in Human Hepatocellular Carcinoma through alpha 2-AR/HIF-1 alpha/VEGFA Pathway*[J]. BIOMEDICAL AND ENVIRONMENTAL SCIENCES,2022,35(10):931-942. |
APA | FANG, Tao., LIN, Li., YE, Zhi Jian., FANG, Lian., SHI, Shuai., ... & LI, Tian Zuo. (2022). Dexmedetomidine Promotes Angiogenesis and Vasculogenic Mimicry in Human Hepatocellular Carcinoma through alpha 2-AR/HIF-1 alpha/VEGFA Pathway*. BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 35(10), 931-942. |
MLA | FANG, Tao,et al."Dexmedetomidine Promotes Angiogenesis and Vasculogenic Mimicry in Human Hepatocellular Carcinoma through alpha 2-AR/HIF-1 alpha/VEGFA Pathway*".BIOMEDICAL AND ENVIRONMENTAL SCIENCES 35.10(2022):931-942. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
查看访问统计 |
谷歌学术 |
谷歌学术中相似的文章 |
[FANG, Tao]的文章 |
[LIN, Li]的文章 |
[YE, Zhi Jian]的文章 |
百度学术 |
百度学术中相似的文章 |
[FANG, Tao]的文章 |
[LIN, Li]的文章 |
[YE, Zhi Jian]的文章 |
必应学术 |
必应学术中相似的文章 |
[FANG, Tao]的文章 |
[LIN, Li]的文章 |
[YE, Zhi Jian]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论